A new study carried out by the scientists of the Gladstone Institutes led by the senior researcher Katerina Akassoglou, Ph.D., shows that many of the new drugs currently being tested may not be sufficient to promote repair within the toxic environment of these cells and identifies a different treatment option that could improve myelin repair.
The study, conducted in collaboration with theUC San Diego and the University of Vienna, in Austria, was published in the magazine Brain.
New drugs for multiple sclerosis: here’s what the research says
In those affected by multiple sclerosis, the fatty substance that insulates the nerves of the central nervous system, called myelin, is damaged. This slows the transmission of signals from the brain to the rest of the body, causing movement difficulties, vision problems and cognitive changes.
Read Also
- Ciotti, Retailleau, Pradié: A unique chance to convince for the three candidates for the LR presidency Nov 21, 2022
- Rai: after Fuortes ad, now Sangiuliano at Rai1 and Mellone at Rai2 Jul 10, 2021
- Ríos Piter’s appointment goes against the UDLAP statute: Derbez Jul 15, 2021
- The State Public Prosecution clarifies the penalty for driving a vehicle without a valid driver’s license Jul 10, 2021
- MTV EMA 2022: A night of legends where Taylor Swift, Muse and Ora/Waititi made their own myth Nov 14, 2022
- Prime Video, “The Wheel of Time”: release date, trailer and plot Sep 3, 2021
- From banning technology to announcing the takeover of Kabul on Twitter: why the Taliban changed their position Aug 18, 2021